4-105234028-C-G
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001127208.3(TET2):c.86C>G(p.Pro29Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0319 in 1,613,852 control chromosomes in the GnomAD database, including 2,390 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
NM_001127208.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TET2 | NM_001127208.3 | c.86C>G | p.Pro29Arg | missense_variant | 3/11 | ENST00000380013.9 | |
TET2-AS1 | NR_126420.1 | n.319-56356G>C | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TET2 | ENST00000380013.9 | c.86C>G | p.Pro29Arg | missense_variant | 3/11 | 5 | NM_001127208.3 | A2 |
Frequencies
GnomAD3 genomes AF: 0.0398 AC: 6048AN: 152142Hom.: 278 Cov.: 33
GnomAD3 exomes AF: 0.0629 AC: 15788AN: 250816Hom.: 878 AF XY: 0.0625 AC XY: 8470AN XY: 135524
GnomAD4 exome AF: 0.0311 AC: 45469AN: 1461592Hom.: 2109 Cov.: 34 AF XY: 0.0335 AC XY: 24384AN XY: 727092
GnomAD4 genome AF: 0.0398 AC: 6057AN: 152260Hom.: 281 Cov.: 33 AF XY: 0.0448 AC XY: 3334AN XY: 74460
ClinVar
Submissions by phenotype
not specified Benign:1Other:1
not provided, no classification provided | reference population | ITMI | Sep 19, 2013 | - - |
Benign, criteria provided, single submitter | clinical testing | Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan | Jan 24, 2024 | This variant is classified as Benign based on local population frequency. This variant was detected in 23% of patients studied by a panel of primary immunodeficiencies. Number of patients: 22. Only high quality variants are reported. - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at